Please Wait.....
Report
Chronic Kidney Disease [CKD] Nutritional Supplement Market (Nutrition Type: Amino Acid Supplements, Vitamin & Mineral Supplements, Probiotics, Prebiotics/Fibers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
Market Report I 2022-08-26 I 217 Pages I Transparency Market Research
Chronic Kidney Disease Nutritional Supplement Market - Scope of Report
TMR's report on the global chronic kidney disease nutritional supplement market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global chronic kidney disease nutritional supplement market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chronic kidney disease nutritional supplement market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the chronic kidney disease nutritional supplement market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global chronic kidney disease nutritional supplement market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global chronic kidney disease nutritional supplement market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global chronic kidney disease nutritional supplement market.
The report delves into the competitive landscape of the global chronic kidney disease nutritional supplement market. Key players operating in the global chronic kidney disease nutritional supplement market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global chronic kidney disease nutritional supplement market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market chronic kidney disease nutritional supplement.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants' insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover's
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team's expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from "Secondary & Primary Sources" is cross-checked with "TMR Knowledge Repository", which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Kidney Disease Nutritional Supplement Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Average Pricing Per Nutrition Type
5.2. Porter's Five Force Analysis
5.3. COVID-19 Impact Analysis
5.4. Prevalence of Chronic Kidney Diseases Globally
6. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Nutrition Type, 2017-2031
6.3.1. Amino Acid Supplements
6.3.1.1. Alpha-Ketoanalogue Supplements
6.3.1.2. Alpha Lipoic Acid Supplements
6.3.1.3. Others
6.3.2. Vitamin & Mineral Supplements
6.3.3. Probiotics
6.3.4. Prebiotics/Fibers
6.3.5. Others
6.4. Market Attractiveness Analysis, by Nutrition Type
7. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Dosage Form, 2017-2031
7.3.1. Capsule Form
7.3.2. Liquid Form
7.3.3. Powder Form
7.3.4. Others
7.4. Market Attractiveness Analysis, by Dosage Form
8. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
8.3.1. Oral Nutrition (ON)
8.3.2. Enteral Nutrition (EN)
8.4. Market Attractiveness Analysis, by FSMP Mode of Administration
9. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by CKD Stage, 2017-2031
9.3.1. Pre-dialysis Stage 1-2
9.3.2. Pre-dialysis Stage 3-5
9.3.3. Dialysis
9.3.4. End-stage Renal Disease
9.4. Market Attractiveness Analysis, by CKD Stage
10. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Distribution Channel, 2017-2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Stores
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Nutrition Type, 2017-2031
12.2.1. Amino Acid Supplements
12.2.1.1. Alpha-Ketoanalogue Supplements
12.2.1.2. Alpha Lipoic Acid Supplements
12.2.1.3. Others
12.2.2. Vitamin & Mineral Supplements
12.2.3. Probiotics
12.2.4. Prebiotics/Fibers
12.2.5. Others
12.3. Market Value Forecast, by Dosage Form, 2017-2031
12.3.1. Capsule Form
12.3.2. Liquid Form
12.3.3. Powder Form
12.3.4. Others
12.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
12.4.1. Oral Nutrition (ON)
12.4.2. Enteral Nutrition (EN)
12.5. Market Value Forecast, by CKD Stage, 2017-2031
12.5.1. Pre-dialysis Stage 1-2
12.5.2. Pre-dialysis Stage 3-5
12.5.3. Dialysis
12.5.4. End-stage Renal Disease
12.6. Market Value Forecast, by Distribution Channel, 2017-2031
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Stores
12.7. Market Value Forecast, by Country, 2017-2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Nutrition Type
12.8.2. By Dosage Form
12.8.3. By FSMP Mode of Administration
12.8.4. By CKD stage
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Nutrition Type, 2017-2031
13.2.1. Amino Acid Supplements
13.2.1.1. Alpha-Ketoanalogue Supplements
13.2.1.2. Alpha Lipoic Acid Supplements
13.2.1.3. Others
13.2.2. Vitamin & Mineral Supplements
13.2.3. Probiotics
13.2.4. Prebiotics/Fibers
13.2.5. Others
13.3. Market Value Forecast, by Dosage Form, 2017-2031
13.3.1. Capsule Form
13.3.2. Liquid Form
13.3.3. Powder Form
13.3.4. Others
13.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
13.4.1. Oral Nutrition (ON)
13.4.2. Enteral Nutrition (EN)
13.5. Market Value Forecast, by CKD Stage, 2017-2031
13.5.1. Pre-dialysis Stage 1-2
13.5.2. Pre-dialysis Stage 3-5
13.5.3. Dialysis
13.5.4. End-stage Renal Disease
13.6. Market Value Forecast, by Distribution Channel, 2017-2031
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Stores
13.7. Market Value Forecast By Country/Sub-region, 2017-2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Nutrition Type
13.8.2. By Dosage Form
13.8.3. By FSMP Mode of Administration
13.8.4. By CKD stage
13.8.5. By Distribution Channel
13.8.6. By Country/Sub-region
14. Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Nutrition Type, 2017-2031
14.2.1. Amino Acid Supplements
14.2.1.1. Alpha-Ketoanalogue Supplements
14.2.1.2. Alpha Lipoic Acid Supplements
14.2.1.3. Others
14.2.2. Vitamin & Mineral Supplements
14.2.3. Probiotics
14.2.4. Prebiotics/Fibers
14.2.5. Others
14.3. Market Value Forecast, by Dosage Form, 2017-2031
14.3.1. Capsule Form
14.3.2. Liquid Form
14.3.3. Powder Form
14.3.4. Others
14.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
14.4.1. Oral Nutrition (ON)
14.4.2. Enteral Nutrition (EN)
14.5. Market Value Forecast, by CKD Stage, 2017-2031
14.5.1. Pre-dialysis Stage 1-2
14.5.2. Pre-dialysis Stage 3-5
14.5.3. Dialysis
14.5.4. End-stage Renal Disease
14.6. Market Value Forecast, by Distribution Channel, 2017-2031
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies
14.6.3. Online Stores
14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Taiwan
14.7.5. Australia & New Zealand
14.7.6. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Nutrition Type
14.8.2. By Dosage Form
14.8.3. By FSMP Mode of Administration
14.8.4. By CKD stage
14.8.5. By Distribution Channel
14.8.6. By Country/Sub-region
15. Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Nutrition Type, 2017-2031
15.2.1. Amino Acid Supplements
15.2.1.1. Alpha-Ketoanalogue Supplements
15.2.1.2. Alpha Lipoic Acid Supplements
15.2.1.3. Others
15.2.2. Vitamin & Mineral Supplements
15.2.3. Probiotics
15.2.4. Prebiotics/Fibers
15.2.5. Others
15.3. Market Value Forecast, by Dosage Form, 2017-2031
15.3.1. Capsule Form
15.3.2. Liquid Form
15.3.3. Powder Form
15.3.4. Others
15.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
15.4.1. Oral Nutrition (ON)
15.4.2. Enteral Nutrition (EN)
15.5. Market Value Forecast, by CKD Stage, 2017-2031
15.5.1. Pre-dialysis Stage 1-2
15.5.2. Pre-dialysis Stage 3-5
15.5.3. Dialysis
15.5.4. End-stage Renal Disease
15.6. Market Value Forecast, by Distribution Channel, 2017-2031
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies
15.6.3. Online Stores
15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Nutrition Type
15.8.2. By Dosage Form
15.8.3. By FSMP Mode of Administration
15.8.4. By CKD stage
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Nutrition Type, 2017-2031
16.2.1. Amino Acid Supplements
16.2.1.1. Alpha-Ketoanalogue Supplements
16.2.1.2. Alpha Lipoic Acid Supplements
16.2.1.3. Others
16.2.2. Vitamin & Mineral Supplements
16.2.3. Probiotics
16.2.4. Prebiotics/Fibers
16.2.5. Others
16.3. Market Value Forecast, by Dosage Form, 2017-2031
16.3.1. Capsule Form
16.3.2. Liquid Form
16.3.3. Powder Form
16.3.4. Others
16.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
16.4.1. Oral Nutrition (ON)
16.4.2. Enteral Nutrition (EN)
16.5. Market Value Forecast, by CKD Stage, 2017-2031
16.5.1. Pre-dialysis Stage 1-2
16.5.2. Pre-dialysis Stage 3-5
16.5.3. Dialysis
16.5.4. End-stage Renal Disease
16.6. Market Value Forecast, by Distribution Channel, 2017-2031
16.6.1. Hospital Pharmacies
16.6.2. Retail Pharmacies
16.6.3. Online Stores
16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Nutrition Type
16.8.2. By Dosage Form
16.8.3. By FSMP Mode of Administration
16.8.4. By CKD stage
16.8.5. By Distribution Channel
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis/Ranking, by Company, 2021
17.3. Company Profiles
17.3.1. Abbott Laboratories
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. Strategic Overview
17.3.1.5. SWOT Analysis
17.3.2. Ajanta Pharma Limited
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. Strategic Overview
17.3.2.5. SWOT Analysis
17.3.3. Fresenius Kabi AG
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. Strategic Overview
17.3.3.5. SWOT Analysis
17.3.4. Hexagon Nutrition Limited
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.5. Mankind Pharma Ltd.
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Strategic Overview
17.3.5.4. SWOT Analysis
17.3.6. Nestle S.A.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. Strategic Overview
17.3.6.5. SWOT Analysis
17.3.7. Nutricia Limited (Danone S.A.)
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. Strategic Overview
17.3.7.5. SWOT Analysis
17.3.8. PRINE Health MSO, LLC
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. SWOT Analysis
17.3.9. RPG Life Sciences Limited
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. Strategic Overview
17.3.9.5. SWOT Analysis
List of Tables
Table 01: Average Pricing Per Nutrition Type
Table 02: Average Pricing Per Nutrition Type
Table 03: Prevalence of Chronic Kidney Diseases Globally
Table 04: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
Table 05: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
Table 06: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form , 2017-2031
Table 07: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
Table 08: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
Table 09: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 10: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 11: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
Table 12: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
Table 13: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 14: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
Table 15: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
Table 16: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 17: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 18: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
Table 19: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
Table 20: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 21: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
Table 22: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
Table 23: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 24: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 25: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
Table 26: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
Table 27: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 28: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
Table 29: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
Table 30: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 31: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
Table 33: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
Table 34: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form , 2017-2031
Table 35: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
Table 36: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
Table 37: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 38: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 39: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
Table 40: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
Table 41: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form , 2017-2031
Table 42: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
Table 43: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
Table 44: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 45: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
Figure 01: Global Chronic Kidney Disease Nutritional Supplement (CKD) Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
Figure 03: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
Figure 04: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Amino Acid Supplements, 2017-2031
Figure 05: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Vitamin & Mineral Supplements, 2017-2031
Figure 06: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Probiotics, 2017-2031
Figure 07: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Prebiotics/Fibers, 2017-2031
Figure 08: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Others, 2017-2031
Figure 09: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form 2021 and 2031
Figure 10: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 11: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Capsule Form, 2017-2031
Figure 12: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Liquid Form, 2017-2031
Figure 13: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Powder Form, 2017-2031
Figure 14: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Others, 2017-2031
Figure 15: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
Figure 16: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
Figure 17: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Oral Nutrition, 2017-2031
Figure 18: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Enteral Nutrition, 2017-2031
Figure 19: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
Figure 20: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
Figure 21: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Pre-dialysis Stage 1-2, 2017-2031
Figure 22: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Pre-dialysis Stage 3-5, 2017-2031
Figure 23: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Dialysis, 2017-2031
Figure 24: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by End-stage Renal Disease, 2017-2031
Figure 25: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
Figure 26: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 27: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Hospital Pharmacies, 2017-2031
Figure 28: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Retail Pharmacies, 2017-2031
Figure 29: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Online Stores, 2017-2031
Figure 30: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Region, 2021 and 2031
Figure 31: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Region, 2022-2031
Figure 32: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
Figure 33: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
Figure 34: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
Figure 35: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form, 2021 and 2031
Figure 36: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 37: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
Figure 38: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
Figure 39: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
Figure 40: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
Figure 41: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
Figure 42: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 43: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country, 2021 and 2031
Figure 44: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country, 2022-2031
Figure 45: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
Figure 46: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
Figure 47: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
Figure 48: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form. 2021 and 2031
Figure 49: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 50: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
Figure 51: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
Figure 52: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
Figure 53: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
Figure 54: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
Figure 55: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 56: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 57: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 58: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
Figure 59: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
Figure 60: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
Figure 61: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form 2021 and 2031
Figure 62: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 63: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
Figure 64: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
Figure 65: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
Figure 66: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
Figure 67: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
Figure 68: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 69: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 70: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 71: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
Figure 72: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
Figure 73: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
Figure 74: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form, 2021 and 2031
Figure 75: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 76: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
Figure 77: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
Figure 78: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
Figure 79: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
Figure 80: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
Figure 81: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 82: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 83: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 84: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
Figure 85: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
Figure 86: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
Figure 87: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form, 2021 and 2031
Figure 88: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 89: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
Figure 90: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
Figure 91: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
Figure 92: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
Figure 93: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
Figure 94: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 95: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 96: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 97: Global Chronic Kidney Disease Nutritional Supplement Market Share Analysis/Ranking, by Company, 2021
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security